Culture

3D-printed smart gel changes shape when exposed to light

image: This octopus has color-changing cells, called chromatophores, in its skin, a phenomenon that inspired Rutgers engineers.

Image: 
NOAA Okeanos Explorer Program, Galapagos Rift Expedition 2011

Inspired by the color-changing skin of cuttlefish, octopuses and squids, Rutgers engineers have created a 3D-printed smart gel that changes shape when exposed to light, becomes "artificial muscle" and may lead to new military camouflage, soft robotics and flexible displays.

The engineers also developed a 3D-printed stretchy material that can reveal colors when light changes, according to their study in the journal ACS Applied Materials & Interfaces.

Their invention is modeled after the amazing ability of cephalopods such as cuttlefish, octopuses and squids to change the color and texture of their soft skin for camouflage and communication. This is achieved by the thousands of color-changing cells, called chromatophores, in their skin.

"Electronic displays are everywhere and despite remarkable advances, such as becoming thinner, larger and brighter, they're based on rigid materials, limiting the shapes they can take and how they interface with 3D surfaces," said senior author Howon Lee, an assistant professor in the Department of Mechanical and Aerospace Engineering in the School of Engineering at Rutgers University-New Brunswick. "Our research supports a new engineering approach featuring camouflage that can be added to soft materials and create flexible, colorful displays."

Rutgers engineers developed a 3D printable hydrogel, or smart gel, that senses light and changes shape as a result. Hydrogels, which keep their shape and stay solid despite containing water, are found in the human body, Jell-O, diapers and contact lenses, among many examples.

The engineers incorporated a light-sensing nanomaterial in the hydrogel, turning it into an "artificial muscle" that contracts in response to changes in light. The light-sensing smart gel, combined with the 3D-printed stretchy material, changes color, resulting in a camouflage effect.

Next steps include improving the technology's sensitivity, response time, scalability, packaging and durability.

Credit: 
Rutgers University

Viewing upper gastrointestinal cancers in a new light

image: Left. The spectral characteristics of white fluorescence excited by a laser for white light and the short-wavelength laser. LCI expands and reduces color information simultaneously to intensify shades of red and white. Right. LCI enhances the contrast of red and white colors compared with a white light image.

Image: 
Department of Gastrointestinal Surgery,TMDU

Researchers from Tokyo Medical and Dental University (TMDU) describe an endoscopic modality for detecting upper gastrointestinal tract neoplasms by Linked Color Imaging that innovatively mixes light of different wavelengths to better depict mucosal changes

Tokyo, Japan - Recently there have been significant advances on several fronts in the ongoing war against cancer of the alimentary tract. Now, Japanese researchers report the development of another weapon: Linked Color Imaging (LCI), a novel endoscopic technique that improves detection of cancer by viewing the upper digestive tract mucosa under illumination that combines specific wavelengths of light to intensify subtle color variations indicative of neoplastic change.

Upper gastrointestinal (GI) endoscopy is routinely performed to detect tumorous changes or neoplasia in the pharynx, esophagus, and stomach and is conventionally done under White Light Imaging (WLI). Using the innovative LASEREO system developed by the Fujifilm Corporation, LCI technology balances white light with narrow-band short wavelength light in a specific ratio that deepens and enhances the contrast of red and white hues, thus intensifying nuances of mucosal transformation.

Though earlier studies have described the role of LCI in histological diagnosis of upper GI tract tumors, the research team felt the need for a large-scale, broad-based comparative study to assess its efficacy in neoplasm detection. "Our research was conducted in 19 hospitals across Japan involving 1502 patients with known past or current gastrointestinal cancer, representing a high-risk population" explains Dr Shoko Ono, lead author. "Patients underwent upper GI endoscopy under both WLI and LCI protocols wherein they were grouped according to which modality was performed first. Ingeniously, our study design ensured diagnostic accuracy; not only did each modality serve as a backup and crosscheck on the other, this was further followed by histopathological confirmation."

Dr Kenro Kawada, co-lead author, describes the results. "With LCI, lesions were detected in 8% of the patients but the detection rate was only 4.8% with WLI. Conversely, with WLI 3.5% of patients had a lesion overlooked but this rate was only 0.67% with LCI. This shows a clear superiority of LCI over conventionally illuminated endoscopic screening for discerning mucosal changes related to upper GIT neoplasia as it detected neoplasia 1.67 times more frequently."

Professor Mototsugu Kato, senior and corresponding author, explains the implications of their research. "Combined with previous studies that show the efficacy of LCI in detecting large intestinal neoplasia, our findings make a strong case for wider adoption of this modality in surveillance of the entire endoscopically accessible digestive tract. However, we need further research to confirm its efficacy in the hands of general clinicians for upper GI screening of an average population."

Credit: 
Tokyo Medical and Dental University

Dental experts discover biological imbalance is the link between gum and kidney disease

image: Research into link between gum and kidney disease

Image: 
University of Birmingham

An imbalance of the body's oxygen producing free radicals and its antioxidant cells could be the reason why gum disease and chronic kidney disease affect each other, a new study led by the University of Birmingham has found.

Periodontitis - or gum disease - is a common, inflammatory disease which causes bleeding gums, wobbly or drifting teeth and can eventually result in tooth loss.

Previous studies have shown a link between the severe oral inflammation caused by gum disease and chronic kidney disease (CKD) which demonstrated that those with worse inflammation of the gums have worse kidney function.

Previous research also showed that patients with CKD and periodontitis experience a drop in survival rates, similar in magnitude to if they had diabetes instead of gum inflammation, suggesting that gum inflammation may casually affect kidney function.

In this latest study, led by researchers at the University of Birmingham, over 700 patients with chronic kidney disease were examined using detailed oral and full-body examinations including blood samples. The aim was to test the hypothesis that periodontal inflammation and kidney function affect each other and to establish the underlying mechanism that may facilitate this.

Results showed that just a 10% increase in gum inflammation reduces kidney function by 3%. In this group of patients, a 3% worsening in kidney function would translate to an increase in the risk of kidney failure over a 5 year period from 32%-34%. Results also showed that a 10% reduction in kidney function increases periodontal inflammation by 25%.

In contrast to current beliefs that inflammation is the link between periodontitis and other systemic diseases, researchers found for the first time, that in this group of patients, the effect was caused by a biological process called 'oxidative stress' - or, an imbalance between reactive oxygen species and the body's antioxidant capacity which damages tissues on a cellular level.

Lead author Dr Praveen Sharma, from the Periodontal Research Group at the University of Birmingham's School of Dentistry, said: "This is the first paper to quantify the casual effect of periodontitis on kidney function and vice-versa as well as the first to elucidate the pathways involved.

"It showed that even a modest reduction in gum inflammation can benefit renal function. Given the relative ease of achieving a 10% reduction in gum inflammation, through simple measures like correct brushing techniques and cleaning between the teeth, these results are very interesting.

"We hope that this research paves the way for further studies to see if improvements in kidney function, following periodontal care, translate to longer, healthier life for patients with chronic kidney disease. We would also hope that the hypothesis we have identified could be tested in other groups."

Credit: 
University of Birmingham

Looking forwards rather than backwards safeguards wellbeing during Covid-19 lockdowns

Practicing gratitude and looking to the future will help safeguard our mental wellbeing during Covid-19 lockdowns, a new study in the Journal of Positive Psychology reports.

In the first study of its kind, researchers from the University of Surrey investigated the effectiveness of three psychological interventions -- nostalgia, a sentimentality for the past; gratitude, recognising the good things currently in our life; and best possible self, thinking about positive elements of the future -- and how they each affect wellbeing during lockdowns.

Personal characteristics such as emotion regulation (the ability to respond to and manage an emotional experience) and attachment orientations (how a person views their relationships to others) were also examined. It is believed that such traits may be an indicator of how an individual responds to lockdowns.

Investigating which intervention was the most effective, researchers worked with 216 participants who were each assigned to one of four groups, each one practicing either nostalgia, gratitude or best possible self, plus a control group.

Those practicing a nostalgic approach were instructed to think of a sentimental memory in their life that occurred before the lockdown; for gratitude, participants were encouraged to list three things that went well in their day and why this was; and for best possible self those involved were asked to think about where they imagine themselves in the future after lockdown has lifted. Those in the control group were each asked to recall the plot of a recent television or film they had viewed. Participants were then asked about their thoughts and feelings.

Researchers found that those who participated in the best possible self and gratitude interventions reported higher levels of social connectedness than those who practiced nostalgia. Those in the best possible self group were also found to experience significantly more positive emotion than those in the nostalgia group. Researchers believe that gratitude and best possible self direct attention towards positive aspects of a person's life by giving them hope and prevent individuals from dwelling on their current situation.

Amelia Dennis, a postgraduate researcher at the University of Surrey, said: "All three interventions have proven beneficial to people experiencing a difficult time in their life. However, as lockdowns have continued people have been presented with unusual challenges and many have struggled. We found that looking to the future and appreciating what is positive in our lives currently is more psychologically beneficial than reminiscing about the past.

"The current restrictions and any future lockdowns have removed our sense of control of our lives. For the sake of our wellbeing, we need to acknowledge what we do have rather than regretting what we have lost."

Participants were also surveyed on their personal characteristics regarding attachment and emotion regulation. Researchers found that those with low attachment anxiety (i.e. believe they are worthy of love) and those with lower attachment avoidance (i.e. inclined to feel others are trustworthy) were most likely to experience greater wellbeing during lockdown. Those with higher emotion regulation were also found to be more resilient to their current circumstances, which protects their overall wellbeing.

Jane Ogden, Professor of Health Psychology at the University of Surrey, said: "The two lockdowns last year dramatically affected our mental and emotional wellbeing and it is likely any future ones will have the same affect. Reports of increased levels of depression and anxiety are worrying because these can negatively impact upon our physical health. It is important that we understand which psychological techniques can most benefit and support people during unsettling and difficult times."

Credit: 
University of Surrey

Integrator: A guardian of the human transcriptome

image: RNA polymerase II (RNAPII) initiates transcription at a multitude of positions in the human genome. However, only a fraction of these sites is associated with genes that give rise to functional RNA. The 'Integrator' complex by default terminates RNAPII shortly after its initiation (top), unless specific gene-defining elements are present allowing for transition to productive elongation (bottom). In the latter case, transcription is typically terminated by the 'Cleavage & Polyadenylation' Complex that recognizes specific 'terminator' sequence elements in the genome (bottom, red box). In the former case the produced short RNA is by default rapidly degraded by the RNA exosome, whereas snRNAs constitute a special case that avoids degradation.

Image: 
Søren Lykkke-Andersen

In a joint collaboration, Danish and German researchers have characterized a cellular activity that protects our cells from potentially toxic by-products of gene expression. This activity is central for the ability of multicellular organisms to uphold a robust evolutionary 'reservoir' of gene products.

Manufacturing processes need quality control systems in order to ensure proper assembly of functional products. Moreover, space-consuming, and perhaps even toxic, by-products of such processes need to be properly discarded or recycled by efficient waste handling systems.

By analogy, transcription of our genome is an imperfect process that produces large quantities of non-functional and potentially harmful transcripts both from within and outside of conventional genes. The RNA polymerase II enzyme transcribes the majority of our genes, and it also generates pervasive transcripts from multiple non-genic regions. Over the past decade, it has become increasingly clear that the enzyme is relatively promiscuous when it comes to where it starts, and there are transcription initiation sites scattered everywhere in the genome. However, not all these sites are associated with a 'proper' gene, and this requires the presence of specific gene-defining elements.

Discovery of new activity of the protein complex 'Integrator'

In a new article published in the international journal Molecular Cell, a Danish-German research team has now demonstrated that the multi-protein complex 'Integrator' - which was previously described as the transcription termination factor for a specific class of genes encoding small nuclear (sn)RNAs - is in fact a default 'early' termination factor for most, if not all RNA polymerase II initiation events (Figure, top panel).

The resulting short transcripts are in most cases rapidly degraded by the ribonucleolytic RNA exosome. This mechanism is also at play to varying degrees inside conventional genes, but these have evolved elements, counteracting such early termination, to facilitate productive transcription elongation, which eventually produces functional transcripts such as protein-coding 'messenger' (m)RNA (Figure, bottom panel).

Through this newly discovered mechanism of action, Integrator ensures that production of wasteful transcripts remains limited, while at the same time allowing maintenance of thousands of transcription start sites under neutral selection in the human genome. These provide a reservoir of transcription units that may turn into functional genes over time, exemplified by the evolution of the currently known functional RNAs of our genome. As a curious example, snRNA genes appear to be a special case, taking advantage of the general early termination activity of Integrator and fend off the ensuing RNA exosome activity to allow production of stable functional RNAs (Figure, top panel).

Inactivating mutations in Integrator subunits lead to severe neurodevelopmental disorders, and elevated expression of some integrator subunits is associated with increased epithelial-to-mesenchymal transition - a key step in tumor metastasis. This duality highlights the need for a tight control of the Integrator activity. Moreover, the realization that Integrator is a general attenuator of nonproductive transcription may inform the molecular characterization and potential treatment of such ailments.

Credit: 
Aarhus University

Bedside EEG test can aid prognosis in unresponsive brain injury patients

Assessing the ability of unresponsive patients with severe brain injury to understand what is being said to them could yield important insights into how they might recover, according to new research.

A team at the University of Birmingham has shown that responses to speech can be measured using electroencephalography, a non-invasive technique used to record electrical signals in the brain. The strength of these responses can be used to provide an accurate prognosis that can help clinicians make the most effective treatment decisions.

Significantly the assessments can be made while the patient is still in intensive care and does not require any conscious response from the patient - they do not have to 'do' anything.

In the study, published inAnnals of Neurology, the team assessed 28 patients with acute traumatic brain injury (TBI) who were not under sedation, and who failed to obey commands. The patients were assessed within just a few days of their injury. They were played streams of sentences and phrases made up of monosyllabic words while their brain activity was monitored using EEG.

In healthy individuals, EEG activity only synchronises with the rhythm of phrases and sentence when listeners consciously comprehend the speech. The researchers assessed the level of the unresponsive patients' comprehension by measuring the strength of this synchronicity.

The researchers were able to follow up 17 of the patients three months following their injury, and 16 of the patients after six months. They found the outcomes significantly correlated with the strength of the patients' response to speech measured by the EEG.

Patients with traumatic brain injury are commonly assessed by their behaviour or by a CT scan, but some patients who remain unresponsive pose a significant challenge. Recent studies have shown that TBI patients can be shown to 'imagine' themselves following commands. This activity can also be tracked using EEG. However, this approach requires a fairly sophisticated response from the patient, so patients with lower brain capabilities may be overlooked.

Lead author Dr Damian Cruse is based at the University of Birmingham's School of Psychology and Centre for Human Brain Health. He explains: "The strength of our approach is that we can measure a scale of comprehension without needing any other sort of response from the patient. This insight could significantly reduce prognostic uncertainty at a critical point. It could help clinicians make more appropriate decisions about whether or not to continue life-sustaining therapy - and also ensure rehabilitation resources are allocated to patients who are most likely to benefit."

Credit: 
University of Birmingham

Increase in pleasurable effects of alcohol over time can predict alcohol use disorder

A new study out of the University of Chicago Medicine following young adult drinkers for 10 years has found that individuals who reported the highest sensitivity to alcohol's pleasurable and rewarding effects at the start of the trial were more likely to develop an alcohol use disorder (AUD) over the course of the study.

Moreover, when retested on their responses 10 years later, those who became alcoholics had the highest levels of alcohol stimulation, liking and wanting - and these were heightened compared to their baseline with no signs of tolerance to these pleasurable effects.

The research, published on Jan. 5 in the American Journal of Psychiatry, followed a cohort of 190 young adults in a laboratory-based binge-drinking scenario at three regular intervals over the course of 10 years.

These results indicate that individuals developing an AUD are more likely to be sensitized to the effects of alcohol -- that is, they experience a stronger positive response -- rather than habituated to the substance with a lower level of response. In these same individuals, alcohol was less sedating for them from the beginning and this did not change over time.

"Prior longitudinal studies have looked at young drinkers' response to alcohol and focused primarily on the fatiguing and impairing effects of alcohol," said lead author Andrea King, PhD, professor of psychiatry and behavioral neuroscience at UChicago Medicine. "The thinking that alcoholics do not like the effects of alcohol over time is based on ad-hoc reports of patients entering treatment. Only by testing the same people over a substantial amount of time to see if alcohol responses change over time were we able to observe this elevated response to alcohol compared with placebo, and in participants who did not know the contents of the drinks, so expectancy effects were minimized."

The study showed that higher sensitivity to the euphoric and rewarding effects of alcohol can predict who will go on to have an AUD as they progress through their 20s and 30s.

"These pleasurable alcohol effects grow in intensity over time, and do not dissipate, in people progressing in excessive drinking," said King. "This tells us that having a higher sensitivity to the rewarding effects of alcohol in the brain puts such individuals at higher risk for developing addiction. It all fits a picture of persistent pleasure-seeking that increases the likelihood of habitual excessive drinking over time. Alcoholics were thought to need to drink more to finally get their desired effect when they drink, but these well-controlled data do not support that contention. They get the desirable alcohol effect early in the drinking bout and that seems to fuel wanting more alcohol."

While it may seem relatively intuitive that individuals who experience alcohol's pleasurable effects most intensely are at the greatest risk for developing drinking problems, King's findings run counter to current prominent addiction theories.

"Our results support a theory called incentive-sensitization," said King. "In response to a standard intoxicating dose of alcohol in the laboratory, ratings of wanting more alcohol increased substantially over the decade among the individuals who developed more severe AUD. Additionally, the hedonic response -- essentially, how much a person liked the effects -- remained elevated over this interval and didn't go down at all. This has traditionally been the crux of the lore of addiction - that addicts don't like the drug (alcohol) but can't stop using it."

The participants were regular light or heavy social drinkers in their mid-20s at the start of the trial from 2004 to 2006. They were brought back for repeated testing of alcohol responses in the laboratory five and 10 years later as they approached middle adulthood. In between testing periods, participants were interviewed at near-annual intervals to track their drinking patterns and symptoms of AUD over time.

King hopes that these results can help improve our understanding of how some individuals have more vulnerability to developing AUD, while others remain social drinkers over their lifespan. She also points out that the results can help to develop better treatments for AUDs and inform earlier interventions for individuals who may be at high risk for developing an addiction.

"I'm already using this information to inform how I talk about addiction with my therapy clients," King said. "It can be frustrating for them to see other people who can have a couple drinks and just stop there. They can't understand why they repeatedly seem unable to do that, too, and I tell them, it may be because your brain responds differently to alcohol that makes it harder to stop drinking once you start. Knowing that information can empower a person to make different decisions. Even with our current pandemic, a person may drink to cope with stress or reduce negative feelings, but that doesn't mean that they don't also experience the buzz, or pleasurable effects from drinking. This is most concerning for at-risk drinkers as those responses may intensify as they progress with heavier drinking."

Based on this research, King sees the potential for a sort of "personalized medicine" approach for treating AUDs, describing how sharing an individual's "thumbprint" response to alcohol can make a difference in how they think about their consumption.

"This could be an opportunity for early intervention, comparable to how someone may get their cholesterol tested and then may be more motivated to change their diet, exercise more or start a medication to rein it in," King said. "Similarly, knowing one's acute response to alcohol and how it may indicate a person's future risk for drinking problems, one may decide to change their drinking on their own or seek help to avoid the progression to addiction."

Credit: 
University of Chicago Medical Center

Eurasian eagle owl diet reveals new records of threatened giant bush-crickets

image: Male specimen of the Big-Bellied Glandular Bush-Cricket (Bradyporus macrogaster)

Image: 
Dragan Chobanov

Bird diets provide a real treasure for research into the distribution and conservation of their prey, such as overlooked and rare bush-cricket species, point out scientists after studying the diet of the Eurasian Eagle Owl (Bubo bubo) in southeastern Bulgaria.

In their paper, published in the open-access, peer-reviewed journal Travaux du Muséum National d'Histoire Naturelle "Grigore Antipa", Dr Dragan Chobanov (Institute of Biodiversity and Ecosystem Research, Bulgaria) and Dr Boyan Milchev (University of Forestry, Bulgaria) report the frequent presence of the threatened with extinction Big-Bellied Glandular Bush-Cricket (Bradyporus macrogaster) in the diet of Eurasian Eagle Owls, and conclude that the predatory bird could be used to identify biodiversity-rich areas in need of protection.

While the Balkan Peninsula has already been recognised as the area with the highest diversity of orthopterans (grasshoppers, crickets and bush-crickets) in Europe and one of the generally most biologically diverse areas in the whole Palearctic realm, it is also home to a worrying number of threatened species. Additionally, a thorough and updated country assessment of the conservation status of the orthopterans found in Bulgaria is currently lacking. This is why the Bulgarian team undertook a study on the biodiversity of these insects by analysing food remains from pellets of Eurasian Eagle Owls, collected from 53 breeding sites in southeastern Bulgaria.

As a result, the scientists reported three species of bush crickets that have become a significant part of the diet of the studied predatory birds. Curiously enough, all three species are rare or threatened in Bulgaria. The case of the Big-Bellied Glandular Bush-Cricket is of special concern, as it is a species threatened by extinction. Meanwhile, the local decline in mammals and birds that weigh between 0.2 and 1.9 kg, which are in fact the preferred prey for the Eurasian Eagle Owl, has led the highly opportunistic predator to increasingly seek large insects for food. The researchers even suspect that there might be more overlooked species attracting the owls.

Taking into account the hereby reported interconnected inferences of conservation concern, as well as the vulnerability of the Big-Bellied Glandular Bush-Cricket, a species with a crucial role in the food chain, the scientists call for the newly provided data to prompt the designation of a new Natura 2000 site. Additionally, due to the species' requirements for habitats of low disturbance and high vegetation diversity, and its large size and easy location via singing males, they point out that it makes a suitable indicator for habitat quality and species community health.

Credit: 
Pensoft Publishers

Long live the efficient, pure-blue OLED

image: Highly efficient, pure-blue organic light-emitting diodes (OLEDs) developed by researchers at Kyushu University in Japan are being tested to measure their lifetime. Based on hyperfluorescence, which uses a two-molecule process to emit light, the OLEDs emit pure-blue emission and exhibit significantly improved lifetimes compared to other highly efficient devices, all without using expensive metal atoms.

Image: 
Masaki Tanaka, Kyushu University

Using a new combination of emitter molecules, researchers in Japan have demonstrated the promise of a novel approach to finally overcome a major challenge facing displays using organic light-emitting diodes: a blue light source matching the excellent performance of the red and green ones.

By splitting energy conversion and emission processes between two molecules, the researchers achieved devices that produce pure-blue emission with high efficiency, maintain brightness for relatively long times, and lack any expensive metal atoms--a set of properties that has so far been difficult to obtain simultaneously.

Acclaimed for their vibrant colors and ability to form thin and even flexible devices, organic light-emitting diodes, or OLEDs for short, use carbon-containing molecules to convert electricity into light.

Unlike LCD technologies employing liquid crystals to selectively block emission from a filtered backlight covering many pixels, the separate red, green, and blue emitting pixels of an OLED display can be completely turned on and off individually, producing deeper blacks and reducing power consumption.

However, blue OLEDs in particular have been a bottleneck in terms of efficiency and stability.

"A growing number of options exist for red and green OLEDs with excellent performance, but devices emitting high-energy blue light are more of a challenge, with tradeoffs almost always occurring among efficiency, color purity, cost, and lifetime," says Chin-Yiu Chan, a researcher at Kyushu University's Center for Organic Photonics and Electronics Research (OPERA) and author on the study reporting the results in Nature Photonics.

While stable blue emitters based on a process known as fluorescence are often used in commercial displays, they suffer from a low maximum efficiency. So-called phosphorescent emitters can achieve an ideal quantum efficiency of 100%, but they generally exhibit shorter operational lifetimes and require an expensive metal such as iridium or platinum.

As an alternative, OPERA researchers have been developing molecules that emit light based on the process of thermally activated delayed fluorescence, commonly abbreviated as TADF, which can achieve excellent efficiency without the metal atom but often exhibits emission containing a wider range of colors.

"The range of colors a display can produce is directly related to the purity of the red, green, and blue pixels," explains Chihaya Adachi, director of OPERA. "If blue emission is not pure with a narrow spectrum, filters are needed to improve the color purity, but this wastes emitted energy."

Takuji Hatakeyama's group at Kwansei Gakuin University recently reported a promising path to overcome the purity issue based on a unique molecular design for a highly efficient, pure-blue TADF emitter, but the molecule, named ν-DABNA, quickly degrades under operation.

Collaborating with Hatakeyama, the OPERA researchers have now found that lifetime can be greatly improved while still obtaining narrow emission by combining ν-DABNA with an additional TADF molecule developed at OPERA as an intermediate, high-speed energy converter.

"Three-fourths of electrical charges combine to form energy states called triplets in OLEDs, and TADF molecules can convert these non-emitting triplets into light-emitting singlets," explains Masaki Tanaka, an OPERA researcher who worked closely with Chan on the study.

"However, ν-DABNA is somewhat slow at converting the high-energy triplets, which often play a role in degradation. To get rid of the dangerous triplets more quickly, we included an intermediary TADF molecule that can more rapidly convert triplets into singlets."

Though the intermediary molecule is fast at converting triplets to singlets, it has a wide emission spectrum producing a sky-blue emission. Nonetheless, the intermediary can transfer many of its singlets in a high-energy state to ν-DABNA for fast and pure blue emission.

"Compared to most emitters, the wavelengths that ν-DABNA can absorb are very close to the color it emits. This unique property makes it able to receive much of the energy from the wide-emission intermediary and still emit a pure blue," says Chan.

Using this two-molecule approach, which has been termed hyperfluorescence, the researchers achieved longer operational lifetimes at high brightness than previously reported for highly efficient OLEDs having a similar color purity.

"That this kind of approach can extend the lifetime of pure-blue emission from a molecule we previously developed is really exciting," says Hatakeyama.

Adopting a tandem structure that basically stacks two devices on top of each other to effectively double the emission for the same electrical current, lifetime was nearly doubled at high brightness, and the researchers estimated that devices could maintain 50% of their brightness for over 10,000 hours at more moderate intensities.

"Though this is still too short for practical applications, stricter control of fabrication conditions often leads to even longer lifetimes, so these initial results point to a very promising future for this approach to finally obtain an efficient and stable pure-blue OLED," says Adachi.

"In the near future, I hope that blue hyperfluorescence OLEDs can replace current blue OLEDs for ultra-high-definition displays," adds Chan.

Credit: 
Kyushu University

For moms, oxygen during childbirth often unnecessary

Babies who suffer oxygen deficiencies during birth are at risk of brain damage that can lead to developmental delays, cerebral palsy and even death. To prevent this, most women in labor undergo continuous monitoring of the baby's heart rate and receive supplemental oxygen if the heart rate is abnormal, with the thought that this common practice increases oxygen delivery to the baby. However, there is conflicting evidence about whether the long-recommended practice improves infant health.

Now, a comprehensive analysis - led by Washington University School of Medicine in St. Louis - looking at 16 previous trials of the practice has found no benefit in providing supplemental oxygen to mothers during labor and delivery. Infants born to women who received supplemental oxygen fared no better or no worse than those born to women who had similar labor experiences but breathed room air.

The findings are published Jan. 4 in JAMA Pediatrics.

Each year, 1.5 million women in the U.S. -- two out of three pregnant women -- receive supplemental oxygen at some point during childbirth, according to the researchers.

The decades-long practice is recommended by the American College of Obstetricians and Gynecologists to treat abnormal fetal heart rates, which may indicate the baby's oxygen levels are low and pose health risks.

"It is such a common practice because the thought is that by giving mom oxygen, we are increasing oxygen transfer to the baby," said the study's first author, Nandini Raghuraman, MD, an assistant professor of obstetrics and gynecology in the Division of Maternal-Fetal Medicine. "However, the results of this study suggest that oxygen is not helpful in these cases and that the practice could be safely discontinued for many women."

Raghuraman added that supplemental oxygen is given mostly as a preventive measure, a practice that began during the 1960s. "Fetal monitoring can indicate a possible abnormal issue such as oxygen deprivation," she said. "But about 80% of the time, women giving birth fall into an intermediate category, in which cases are not completely benign but also not high-risk. And in cases such as these, supplementing oxygen offers no additional benefits."

For the analysis, the researchers examined 16 studies published from 1982 through 2020 of randomized controlled trials in humans -- including one from School of Medicine researchers -- involving more than 2,052 women in childbirth. "Overall, the studies produced mixed results, with some indicating a benefit and others indicating no benefit," Raghuraman said. "That was the reason for doing a meta-analysis. By pooling the numbers of patients across the studies we could get a more definitive answer than looking at individual studies."

The researchers evaluated the pH levels of the babies' blood from samples taken shortly after birth. The pH measures the body's acidity and alkalinity in blood and other fluids, with neutral equaling pH value of 7. For infants, Raghuraman said anything less than 7.1 is considered abnormal and indicates oxygen deprivation.

The researchers also compared neonatal intensive care admission rates and Apgar scores - a well-established test to evaluate newborn health at one and five minutes after birth. Apgar scores check a baby's heart rate, breathing and other signs to determine if the baby needs additional medical care.

"Comparing the health of the babies whose mothers received oxygen and those whose mothers didn't, we found that the differences were essentially zero," Raghuraman said.

Forgoing oxygen supplementation would help reduce an unnecessary intervention and likely reduce health-care costs. "It's been shown that moms, despite having health insurance, often incur steep out-of-pocket costs related to childbirth," Raghuraman said. "Although oxygen is generally an inexpensive intervention compared with other labor and delivery services, minimizing any unnecessary procedure is important."

At Barnes-Jewish Hospital, where Raghuraman delivers babies, the findings have begun to influence clinical care. "We're being more judicious about giving supplemental oxygen to women during labor."

Past studies have indicated that supplementing oxygen may be beneficial to women delivering via cesarean section; however, Raghuraman said more research is needed. "We also want to look at whether exposing mom and baby to prolonged oxygen during labor may be harmful," she said. "Outside of labor and delivery, a lot of research shows that over-oxygenation is associated with oxidative stress that can cause the kind of cellular damage that has been implicated in conditions such as cerebral palsy and Alzheimer's disease. Our findings contradict a general myth that oxygen bars and other ways of increasing oxygen intake is healthy and helpful to a person's overall well-being."

Credit: 
Washington University School of Medicine

Subscriptions to satellite alerts linked to decreased deforestation in Africa

image: The research covered 22 tropical countries, outlined in orange, across South America, Africa and Asia. Forest cover in 2010 is indicated in green.

Image: 
Fanny Moffette / University of Wisconsin–Madison

MADISON, Wis. -- Deforestation dropped by 18 percent in two years in African countries where organizations subscribed to receive warnings from a new service using satellites to detect decreases in forest cover in the tropics.

The carbon emissions avoided by reducing deforestation were worth between $149 million and $696 million, based on the ability of lower emissions to reduce the detrimental economic consequences of climate change.

Those findings come from new research into the effect of GLAD, the Global Land Analysis and Discovery system, available on the free and interactive interface Global Forest Watch. Launched in 2016, GLAD provides frequent, high-resolution alerts when it detects a drop in forest cover. Governments and others interested in halting deforestation can subscribe to the alerts on Global Forest Watch and then intervene to limit forest loss.

The research was led by Fanny Moffette, a postdoctoral researcher in applied economics in the Nelson Institute for Environmental Studies and the Department of Agricultural and Applied Economics at the University of Wisconsin-Madison. Moffette collaborated with Jennifer Alix-Garcia at Oregon State University, Katherine Shea at the World Resources Institute and Amy Pickens at the University of Maryland.

The researchers published their findings Jan. 4 in Nature Climate Change. They studied deforestation in 22 tropical countries across South America, Africa and Asia from 2011 to 2018.

Moffette and her co-authors set out to understand whether these kinds of automated alerts could achieve their goal of reducing forest loss, which has global climate implications. Land-use changes like deforestation account for 6 percent to 17 percent of global carbon emissions. And avoiding deforestation is several times more effective at reducing carbon emissions than regrowing forests.

"The first question was to look at whether there was any impact from having access to this free alert system. Then we were looking at the effect of users subscribing to this data to receive alerts for a specific area," says Moffette.

Simply being covered by GLAD did not help a country combat deforestation. Only those African countries in which organizations had actually subscribed to receive alerts saw a decrease in deforestation. Intuitively, this finding makes sense, says Moffette. Having access to information is good. But what you need to change the course of deforestation are people committed to using that information and acting.

However, deforestation did not decrease in South American or Asian countries, even where organizations subscribed to receive warnings. There are multiple potential causes for this continental discrepancy.

"We think that we see an effect mainly in Africa due to two main reasons," says Moffette. "One is because GLAD added more to efforts in Africa than on other continents, in the sense that there was already some evidence of countries using monitoring systems in countries like Indonesia and Peru. And Colombia and Venezuela, which are a large part of our sample, had significant political unrest during this period."

The GLAD program is still young, and as more governments and organizations sign on to receive warnings, and decide how to intervene at sites of deforestation, the system's influence may grow.

Developed by a team at the University of Maryland that includes one of Moffette's collaborators, GLAD made several improvements over its predecessors. It has very high spatial resolution, roughly 900 square meters, which is orders of magnitude more precise than older tools. And it can provide alerts up to every eight days if the skies are cloud-free when satellites re-image a section of Earth. Users can define custom areas to monitor. They then receive weekly emails, available in six languages, that contain geographic coordinates of the alerts within the monitored areas.

Going forward, the team is looking to evaluate the effect of new features of the monitoring platform, such as data that can inform forest restoration, while supporting efforts of organizations that try to intervene to halt deforestation.

"Now that we know subscribers of alerts can have an effect on deforestation, there's potential ways in which our work can improve the training they receive and support their efforts," says Moffette.

Credit: 
University of Wisconsin-Madison

How to identify heat-stressed corals

image: The rice coral Montipora capitata in waters near the Hawai'i Institute of Marine Biology on Moku o Lo?e in Kāne'ohe Bay, Hawaii.

Image: 
D. Bhattacharya

Researchers have found a novel way to identify heat-stressed corals, which could help scientists pinpoint the coral species that need protection from warming ocean waters linked to climate change, according to a Rutgers-led study.

"This is similar to a blood test to assess human health," said senior author Debashish Bhattacharya, a Distinguished Professor in the Department of Biochemistry and Microbiology in the School of Environmental and Biological Sciences at Rutgers University-New Brunswick. "We can assess coral health by measuring the metabolites (chemicals created for metabolism) they produce and, ultimately, identify the best interventions to ensure reef health. Coral bleaching from warming waters is an ongoing worldwide ecological disaster. Therefore, we need to develop sensitive diagnostic indicators that can be used to monitor reef health before the visible onset of bleaching to allow time for preemptive conservation efforts."

Coral reefs provide habitat, nursery and spawning grounds for fish, food for about 500 million people along with their livelihoods, and coastline protection from storms and erosion. But global climate change threatens corals by warming ocean waters, resulting in coral bleaching and disease. Other threats to corals include sea-level rise, a more acidic ocean, unsustainable fishing, damage from vessels, invasive species, marine debris and tropical cyclones, according to the National Oceanic and Atmospheric Administration.

The study, published in the journal Science Advances, examined how Hawaiian stony corals respond to heat stress, with a goal of identifying chemical (metabolite) indicators of stress. Heat stress can lead to the loss of algae that live in symbiosis with corals, resulting in a white appearance (bleaching) and, potentially, the loss of reefs.

YouTube video: How to build a Coral Hospital

Scientists subjected the heat-resistant Montipora capitata and heat-sensitive Pocillopora acuta coral species to several weeks of warm seawater in tanks at the Hawai'i Institute of Marine Biology. Then they analyzed the metabolites produced and compared them with other corals not subjected to heat stress.

"Our work, for the first time, identified a variety of novel and known metabolites that may be used as diagnostic indicators for heat stress in wild coral before or in the early stages of bleaching," Bhattacharya said.

The scientists are validating their coral diagnosis results in a much larger study and the results look promising. The scientists are also developing a "coral hospital" featuring a new lab-on-a-chip device, which could check coral health in the field via metabolite and protein indicators.

Credit: 
Rutgers University

Frequent travel could make you 7% happier

VANCOUVER, Wash. --People dreaming of travel post-COVID-19 now have some scientific data to support their wanderlust.

A new study in the journal of Tourism Analysis shows frequent travelers are happier with their lives than people who don't travel at all.

Chun-Chu (Bamboo) Chen, an assistant professor in the School of Hospitality Business Management at Washington State University, conducted a survey to find out why some individuals travel more frequently than others and whether or not travel and tourism experiences have a prolonged effect on happiness and wellness.

The results of his analysis show individuals who pay more attention to tourism-related information and frequently discuss their travel plans with friends are more likely to go on regular vacations than those who aren't constantly thinking about their next trip.

Additionally, participants in the survey who reported regularly traveling at least 75 miles away from home also reported being about 7% happier when asked about their overall well-being than those who reported traveling very rarely or not at all.

"While things like work, family life and friends play a bigger role in overall reports of well-being, the accumulation of travel experiences does appear to have a small yet noticeable effect on self-reported life satisfaction," Chen said. "It really illustrates the importance of being able to get out of your routine and experience new things."

Previous studies have examined the stress relief, health and wellness benefits of tourism experiences, but they have tended to examine the effect of a single trip or vacation. Chen's research takes these previous studies one step further by looking at the sustained benefits of travel over the course of a year.

Participants in the study were asked about the importance of travel in their lives, how much time they spent looking into and planning future vacations, and how many trips they went on over a year. They were also asked about their perceived life satisfaction. Out of the 500 survey participants, a little over half reported going on more than four pleasure trips a year. Only 7% of respondents did not take any vacations.

As travel restrictions due to COVID-19 begin to relax in the future, the research could have important implication for both tourists and the tourism industry. Based on the results of the study, Chen said travel companies, resorts and even airlines could launch social media campaigns, such as creating hashtags about the scientific benefits of vacation, to spark people's interest in discussing their opinions about travel.

"This research shows the more people talk about and plan vacations the more likely they are to take them," he said. "If you are like me and chomping at the bit to get out of dodge and see someplace new, this research will hopefully be some additional good motivation to start planning your next vacation."

Credit: 
Washington State University

Results of comprehensive SARS-CoV-2 animal model study published in Nature Microbiology

San Antonio, Texas (January 4, 2020) - Scientists at Texas Biomedical Research Institute (Texas Biomed) and Southwest National Primate Research Center (SNPRC) published their findings regarding a comprehensive animal model study of SARS-CoV-2 in the peer-reviewed journal Nature Microbiology. These findings were originally posted online in BioRxiv in June of 2020. The study evaluated three nonhuman primate (NHP) species (Indian rhesus macaques, African baboons and new-world origin common marmosets) and young and old animals, to determine susceptibility to the SARS-CoV-2 virus and the development of COVID-19 disease. Over the course of the study, the macaque and baboon models showed significant promise as animal models for COVID-19 disease studies moving forward. Based on outcomes, the researchers recommended use of the macaque as a model to help develop vaccines, while the baboon showed greater disease development, making it a potential option for evaluating anti-viral therapeutics and co-morbidities, such as understanding the connection between COVID-19 and diabetes or COVID-19 and heart disease.

"Thanks to the support of our community, Texas Biomed was able to launch and complete the most comprehensive animal model study to date (June 2020) that has provides scientists greater understanding of the immune response to SARS-CoV-2 and definitively identifies two possible animal models to help move vaccines and therapeutics forward," said Larry Schlesinger, M.D., Texas Biomed President and CEO. "The speed and completeness to which this team of researchers operated to execute this study is nothing short of heroic. I am very pleased at the progress the Institute is making in our COVID-19 studies and believe this is the first of many discoveries to come."

COVID-19 is the defining pandemic of a generation. Texas Biomed launched this study in late March 2020 because animal models are a critical component of the biomedical pipeline necessary to fast track drug and vaccine development. The study was completed by May 2020.

"The benefit of Texas Biomed's unique research model lies in the expertise to support individual scientific study and contract research on one campus with the animal, biosafety and regulatory proficiency to help shepherd research from basic discovery through preclinical development and on to human clinical trials," explained Joanne Turner, PhD, Vice President for Research at Texas Biomed.

Animal models for infectious diseases, such as COVID-19, are allowing scientists worldwide to determine whether the candidate vaccines and antiviral therapeutics currently under development will be viable as human interventions. Additionally, animal models enable scientists to understand how the disease progresses in people with compromised immune systems to assist in the development of treatments for these individuals.

"Finding the appropriate animal models for COVID-19 allows for these critical discoveries to happen now, and they are an important step in combatting this disease," said Dr. Deepak Kaushal, PhD, Director of the Southwest National Primate Research Center and lead Principal Investigator on the macaque portion of the study. "Without well-documented animal data, the FDA is unlikely to license a vaccine or antiviral therapy for human use, even those currently undergoing human trials, because animal model data assure us that we have a complete picture of the disease and how humans may respond to potential therapies."

The team of 43 researchers reported clinical, viral, imaging, immunological and histopathological (tissue examination) findings during SARS-CoV-2 infection/COVID-19 disease in all three species of NHPs. The study ultimately found that nonhuman primates showed similar progression of SARS-CoV-2 infection to that of humans, with some becoming more ill than others, and signs of the virus in both the upper and lower respiratory tracts and signs of pneumonia.

"Our results tell us that these animal models will provide relevant, quantifiable information moving forward as we delve deeper into understanding the disease and targets for therapeutics and vaccines for human trials," Dr. Kaushal explained.

While previous animal studies showed the macaque to be a viable model for SARS-CoV-2, this was the first time that researchers performed a longitudinal study of three different NHPs (looking at disease progression factors over several days) and in both young and older macaques to determine if age is a factor in disease progression. Moreover, the researchers used the most comprehensive set of evaluations, ranging from bronchoalveolar lavages (lung fluid collection) and nasal swabs to determine virus presence to chest x-rays and CT scans to evaluate lung health after infection.

Results showed that the macaque and baboon models develop strong signs of acute viral infection leading to pneumonia, and the NHP immune system mounts a strong response and clears the infection. Specialized sets of myeloid cells (phagocytes) move from blood to the lungs and secrete high levels of Type I interferons, cytokines or proteins that send chemical messages required for controlling viruses in general and coronaviruses in particular. The appearance of these specialized phagocytes (cells that ingest foreign particles or dying cells in the body) corresponded with a decline in measurable amounts of virus and disease parameters. The longitudinal study of young and old animals showed little difference. However, the virus appears to persist and shed longer in the baboons and create greater pathology in the lungs. The marmoset model did not show any significant signs of disease progression.

This study was also the first report of SARS-CoV-2 infection specifically altering lymphoid cells (T cells) in the lung, which generated a strong and very specific immune response in the macaque, enabling the animals to clear the virus. This finding indicates the NHP model will be useful in understanding the immune response to SARS-CoV-2 and aid in the development of interventions that can create a similar response, as well as help evaluate the safety and effectiveness of vaccines, which require a specific immune response in order to be effective.

"While this study was not the first to indicate the macaque would serve as a good model for SARS-CoV-2, the study provides strong scientific evidence in support of this model, as well as the first evidence of the baboon model via comprehensive, clinically-relevant and well-documented research with controls," Dr. Kaushal said. "We strongly believe macaques and baboons will be very helpful in evaluating interventions that generate the strong immune response seen in these animal models."

The study was funded by philanthropic support from more than 300 donors after a call-to-action campaign was launched in late March. The campaign raised more than $3.5 million in one week, and additional donor support has brought the total raise for COVID-19 research at Texas Biomed to more than $5.7 million.

Concurrently, Texas Biomed investigators are submitting several grant applications to the National Institutes of Health and other federal agencies to further these study findings and develop novel vaccine candidates, diagnostics and therapeutics. Scientists have already begun collaborative immune system and co-morbidity studies, as well as small animal model development studies in rodents and guinea pigs. Additionally, the Institute is collaborating with several pharmaceutical and research and development partners to test vaccine and therapeutic candidates.

Credit: 
Texas Biomedical Research Institute

Drug discovery study identifies promising new compound to open constricted airways

image: Stephen Liggett, MD, of the University of South Florida Morsani College of Medicine (Tampa, FL), led the cross-disciplinary, preclinical study that identified a promising new compound for opening constricted airways.

Image: 
Photo courtesy of of USF Health

TAMPA, Fla (Jan 4, 2021) — Despite the progress made in managing asthma and chronic obstructive pulmonary disease (COPD), poorly controlled symptoms for both respiratory diseases can lead to severe shortness of breath, hospitalizations or even death.

“Only about 50 percent of asthmatics, and an even lower percentage of people with COPD, achieve adequate control of lung inflammation and airway constriction with currently available medications,” said Stephen Liggett, MD, vice dean for research at the University of South Florida Morsani College of Medicine and a USF Health professor of medicine, molecular pharmacology and physiology, and biomedical engineering. “So, we’re clearly missing something from our drug armamentarium to help all these patients.”

Dr. Liggett’s laboratory has discovered several subtypes of bitter taste receptors (TAS2Rs) — G protein-coupled receptors expressed on human smooth airway muscle cells deep inside the lungs. In asthma and COPD, tightening of smooth muscles surrounding bronchial tubes narrows the airway and reduces air flow, and Dr Liggett’s lab found that these taste receptors open the airway when activated. They are now looking for new drugs to treat asthma and other obstructive lung diseases by targeting smooth muscle TAS2Rs to open constricted airways.

A promising bronchodilator agonist rises to the top

In a preclinical study published Nov. 5 in ACS Pharmacology and Translational Science, Dr. Liggett and colleagues identified and characterized 18 new compounds (agonists) that activate bitter taste receptor subtype TAS2R5 to promote relaxation (dilation) of human airway smooth muscle cells. The cross-disciplinary team found 1,10 phenanthroline-5,6-dione (T5-8 for short) to be the most promising of several lead compounds (drug candidates). T5-8 was 1,000 times more potent than some of the other compounds tested, and it demonstrated marked effectiveness in human airway smooth muscle cells grown in the laboratory.

For this drug discovery project, Dr. Liggett’s laboratory collaborated with Jim Leahy, PhD, professor and chair of chemistry at the USF College of Arts and Sciences, and Steven An, PhD, professor of pharmacology at the Rutgers Robert Wood Johnson Medical School.

In an extensive screening conducted previously, another research group identified only one compound that would bind to and specifically activate the TASR5 bitter taste receptor – although apparently with limited effectiveness. Using this particular agonist (called T5-1 in the paper) as a starting point, the team relied on their collective disciplines to devise new activators, aiming for a much better drug profile for administration to humans.

“The two key questions we asked were: ‘Is it possible to find a more potent agonist that activates this receptor?’ and ‘Is it feasible to deliver by inhalation given the potencies that we find?’” said Dr. Liggett, the paper’s senior author. “T5-8 was the bronchodilator agonist that worked best. There were a few others that were very good as well, so we now have multiple potential new drugs to carry out the next steps.”

The researchers developed screening techniques to determine just how potent and effective the 18 compounds were. A biochemical test assessed how well these new agonists activated TAS2R5 in airway smooth muscle cells isolated from non-asthmatic human donor lungs. Then, the researchers validated the effect on airway smooth muscle relaxation using a technique known as magnetic twisting cytometry, pioneered by Dr An.

“Team science” solves a structural problem

“The biggest challenge we faced was not having a 3-D crystal structure of TAS2R5, so we had no idea exactly how agonist T5-1 fit into this mysterious bitter taste receptor,” Dr. Liggett said. “By merging our strength in receptors, pharmacology, physiology, and drug development, our team was able to make the breakthrough.”

T5-8 was superior to all the other bronchodilator agonists screened, exhibiting a maximum relaxation response (50%) substantially greater than that of albuterol (27%). Albuterol belongs to the only class of direct bronchodilators (beta-2 agonists) available to treat wheezing and shortness of breath caused by asthma and COPD. However, this drug or its derivatives, often prescribed as a rescue inhaler, does not work for all patients and overuse has been linked to increased hospitalizations, Dr. Liggett said. “Having two distinct classes of drugs that work in different ways to open the airways would be an important step to help patients optimally control their symptoms.”

The ACS Pharmacology paper highlights the importance of translational research in bridging the gap between laboratory discoveries and new therapies to improve human health, he added. “This study yielded a drug discovery that successfully meets most of the criteria needed to advance the compound toward its first trial as a potential first-in-class bronchodilator targeting airway receptor TAS2R5.”

Credit: 
University of South Florida (USF Health)